Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01279174
Other study ID # Ortho-Koeln-1-2011
Secondary ID Version V1.55
Status Completed
Phase Phase 4
First received January 18, 2011
Last updated December 8, 2015
Start date June 2012
Est. completion date October 2015

Study information

Verified date December 2015
Source University of Cologne
Contact n/a
Is FDA regulated No
Health authority Germany: Federal Institute for Drugs and Medical Devices
Study type Interventional

Clinical Trial Summary

Osteoarthritis (OA) is the most common degenerative arthropathy. Load-bearing joints such as knee and hip are more often affected than spine or hands. The prevalence of gonarthrosis is generally higher than that of coxarthrosis.

Because no cure for OA exists, the main emphasis of therapy is analgesic treatment through either mobility or medication. Non-pharmacologic treatment is the first step, followed by the addition of analgesic medication, and ultimately by surgery.

The goal of non-pharmacologic and non-invasive therapy is to improve neuromuscular function, which in turn both prevents formation of and delays progression of OA. A modification of conventional physiotherapy, whole body vibration has been successfully employed for several years. Since its introduction, this therapy is in wide use at our facility not only for gonarthrosis, but also coxarthrosis and other diseases leading to muscular imbalance.


Description:

This study is a randomized, therapy-controlled trial in a primary care setting at a university hospital. Patients presenting to our outpatient clinic with initial symptoms of coxarthrosis will be assessed against inclusion and exclusion criteria. After patient consent, 6 weeks of treatment will ensue. During the six weeks of treatment, patients will receive one of two treatments, conventional physiotherapy or whole-body-vibration exercises of one hour three times a week. Follow-up examinations will be performed immediately after treatment and after another 6 and 20 weeks, for a total study duration of 6 months. 20 patients will be included in each therapy group.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date October 2015
Est. primary completion date June 2015
Accepts healthy volunteers No
Gender Both
Age group 30 Years to 80 Years
Eligibility Inclusion Criteria:

- Age 30 - 80 years

- Body weight less than or equal to 160 kg

- Body-Mass-Index less than 40 kg/m²

- Outpatient

- Legal competence

- Signed informed consent

- Uni- or bilateral Coxarthrosis according to ACR criteria

- WOMAC-pain index (visual analogue scale) of 30-70 mm

- Coxarthrosis stage II-III according to Kellgren and Lawrence

Exclusion Criteria:

- Participation in parallel interventional studies

- Bilateral Coxarthrosis with WOMAC Pain index more than 70 mm

- Previous surgery during the past 6 months at the Index Joint

- Injury of the study joint during the last 6 months

- Secondary rheumatoid or septic arthrosis or systemic diseases affecting the study joint

- Activated coxarthrosis with intraarticular effusion

- Body weight > 160 kg or body mass index > 40 kg/m²

- Analgesic therapy with steroidal drugs

- Physiotherapy of the lower extremities during the past 6 weeks

- Existing endoprosthetics in the lower extremities

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
Conventional physiotherapy
Patients in this study group will attend physiotherapeutic exercise sessions of one hour three times a week for six weeks. The sessions consist of aerobic and muscle strengthening as well as coordination exercises. Patients will practice activities of daily living. The goals of these exercises are to improve joint stability, optimize knee and ankle proprioception, and advance neuromuscular innervation of the lower extremity and thereby suppress pathologic motion patterns. This should lead to optimized mobility, increased stability, and thus more endogenous analgesia of the affected joint

Locations

Country Name City State
Germany University Hospital Cologne

Sponsors (1)

Lead Sponsor Collaborator
University of Cologne

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in Womac The primary outcome measure is the patients' evaluation of improvement on the visual analogue scale of the WOMAC indices for pain and activities of daily life, comparing baseline and post-treatment. The secondary outcome measures summarized in the appendices will also be assessed at baseline and after 6, 12, and 26 weeks 26 weeks No
Secondary SF-12 The SF-12 score uses subjective patient responses to measure success of therapy and thereby evaluate quality of life. SF-12 is the abbreviated version of the SF-36 Health Survey and contains 12 items representing 8 dimensions of physical and mental fitness. In our study, the validated German translation will be used 26 weeks No
Secondary Leonardo Mechanography Functional motion analysis, the Modified Clinical Test of Sensory Interaction in Balance, the Tandem Walk Test, and the Rhythmic Weight Shift Test will be performed using the Leonardo Mechanography Gangway (Novotec Inc., Pforzheim, Germany) and the Balance Master Analysis System (Neurocom Inc., Clackamas, USA). These will provide reliable data on essential parts of ambulation, e.g. stride length, speed of movement, shifting of balance point, force, power, and workload 26 weeks No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT01326832 - 10 Year Clinical Evaluation of Primoris Hip Component
Completed NCT02399670 - The Influence of Global Femoral-offset Changes After Total Hip Arthroplasty N/A
Completed NCT01046019 - Measurement of Early Bone Loss Around a Total Hip Arthroplasty N/A
Completed NCT00159497 - Bone Remodeling Around HA-coated Acetabular Cups. Phase 4
Not yet recruiting NCT04570748 - Effect of Capsular Repair on the Outcomes of Direct Anterior Total Hip Arthroplasty. N/A
Not yet recruiting NCT01079455 - Comparison of Hyaluronic Acid and Corticosteroid Intra-articular Injections for the Treatment of Osteoarthritis of the Hip Phase 3
Completed NCT00317889 - Compaction Total Hip Arthroplasty (THA) Bilateral N/A
Recruiting NCT04424628 - Radiotherapy 3 vs 6 Gy in Gonarthrosis and Coxarthrosis N/A
Not yet recruiting NCT06272422 - Comparison of the Restoration of Hip Biomechanical Parameters by CT Measurement Between the 3 Surgical Techniques: RSA/Minihip/THA - Hip Replacement: 3D Planning
Completed NCT02694146 - Clinical Trial to Evaluate the Use of Platelet Rich Plasma in Front Hyaluronic Acid in Coxarthrosis Phase 3
Completed NCT02719236 - Direct Anterior Approach Versus Direct Lateral Approach in Total Hip Arthroplasty N/A
Completed NCT05343195 - Balance and Leg Function After Hip Replacement N/A
Active, not recruiting NCT00318396 - Compaction Femur Preparation for Cementless Total Hip Arthroplasty (THA) Unilateral N/A
Completed NCT02338596 - Ultra-Short Anatomic and Conventional Cementless Stems Cementless Stems in Patients Younger Than Fifty-Five Years Old Phase 4
Active, not recruiting NCT00722982 - Migration Pattern of C-stem AMT Versus Exeter in Total Hip Arthroplasty N/A
Completed NCT04903860 - Comparison of the Use of Conventional Ancillary Reaming and Single-use Ancillary Reaming Material in Total Hip Replacement N/A
Recruiting NCT04317872 - Effect of Peri-operative Glucocorticoids on Short-term Functional Outcome After THA N/A
Recruiting NCT03809962 - Efficacy and Safety of Ostenil® Plus in the Treatment of Coxarthrosis
Active, not recruiting NCT01578746 - Comparison Between Anterior and Direct Lateral Approach in Total Hip Arthroplasty Phase 4
Completed NCT00317863 - Zink and Bone Strength N/A